View Past PerformanceHelius Medical Technologies 대차 대조표 상태재무 상태 기준 확인 0/6주요 정보0%부채 비율US$0부채이자 보상 비율n/a현금US$6.39m주식US$6.34m총 부채US$2.51m총 자산US$8.85m최근 재무 상태 업데이트Helius Medical Technologies Receives Non-Compliance Letter from Nasdaq Regarding Minimum Bid Price RequirementAug 10Helius Medical Technologies Receives Written Notice from the Nasdaq Stock MarketApr 07모든 업데이트 표시Recent updatesNew major risk - Share price stability Oct 02Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP StudyOct 01Second quarter 2024 earnings released: US$0.64 loss per share (vs US$2.92 loss in 2Q 2023) Aug 13Helius Medical Technologies Receives Non-Compliance Letter from Nasdaq Regarding Minimum Bid Price RequirementAug 10Helius Medical Technologies, Inc. to Report Q2, 2024 Results on Aug 12, 2024Aug 07Helius Medical Technologies, Inc. Completes Site Participation Enrollment for Its U.S. Registrational Program in StrokeJun 18Helius Medical Technologies, Inc., Annual General Meeting, Jun 27, 2024Jun 05Helius Medical Technologies, Inc. Announces Pons Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage ContractsMay 23First quarter 2024 earnings released: US$3.08 loss per share (vs US$4.42 loss in 1Q 2023) May 15Helius Medical Technologies, Inc. to Report Q1, 2024 Results on May 13, 2024May 12New major risk - Revenue and earnings growth May 12No longer forecast to breakeven May 12Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd CenterApr 25Helius Medical Technologies, Inc. has filed a Follow-on Equity Offering.Apr 16Helius Medical Technologies Receives Written Notice from the Nasdaq Stock MarketApr 07Full year 2023 earnings released: US$14.56 loss per share (vs US$52.13 loss in FY 2022) Mar 30Helius Medical Technologies, Inc. to Report Q4, 2023 Results on Mar 28, 2024Mar 17Helius Medical Technologies, Inc. to Report Q4, 2023 Results on Mar 28, 2024Mar 16Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in StrokeMar 14No longer forecast to breakeven Feb 21재무 상태 분석부채 대 자본 내역 및 분석대차 대조표건강한 기업 발견하기7D1Y7D1Y7D1YHealthcare 업계의 건강한 기업.View Dividend
Helius Medical Technologies Receives Non-Compliance Letter from Nasdaq Regarding Minimum Bid Price RequirementAug 10
Helius Medical Technologies Receives Non-Compliance Letter from Nasdaq Regarding Minimum Bid Price RequirementAug 10
Helius Medical Technologies, Inc. Completes Site Participation Enrollment for Its U.S. Registrational Program in StrokeJun 18
Helius Medical Technologies, Inc. Announces Pons Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage ContractsMay 23
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd CenterApr 25
Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in StrokeMar 14